Limonene Inhibits Methamphetamine-Induced Sensitizations via the Regulation of Dopamine Receptor Supersensitivity

  • Gu, Sun Mi (College of Pharmacy and Medical Research Center, Chungbuk National University) ;
  • Kim, Sung Yeon (College of Pharmacy, Wonkwang University) ;
  • Lamichhane, Santosh (College of Pharmacy, Wonkwang University) ;
  • Hong, Jin Tae (College of Pharmacy and Medical Research Center, Chungbuk National University) ;
  • Yun, Jaesuk (College of Pharmacy and Medical Research Center, Chungbuk National University)
  • Received : 2018.11.04
  • Accepted : 2019.01.14
  • Published : 2019.07.01


Limonene is a cyclic terpene found in citrus essential oils and inhibits methamphetamine- induced locomotor activity. Drug dependence is a severe neuropsychiatric condition that depends in part on changes in neurotransmission and neuroadaptation, induced by exposure to recreational drugs such as morphine and methamphetamine. In this study, we investigated the effects of limonene on the psychological dependence induced by drug abuse. The development of sensitization, dopamine receptor supersensitivity, and conditioned place preferences in rats was measured following administration of limonene (10 or 20 mg/kg) and methamphetamine (1 mg/kg) for 4 days. Limonene inhibits methamphetamine- induced sensitization to locomotor activity. Expression of dopamine receptor supersensitivity induced by apomorphine, a dopamine receptor agonist, was significantly reduced in limonenepretreated rats. However, there was no significant difference in methamphetamine-induced conditioned place preferences between the limonene and control groups. These results suggest that limonene may ameliorate drug addiction-related behaviors by regulating postsynaptic dopamine receptor supersensitivity.



Supported by : National Research Foundation of Korea [NRF]


  1. Allen, R. M. and Young, S. J. (1978) Phencyclidine-induced psychosis. Am. J. Psychiatry 135, 1081-1084.
  2. Bello, E. P., Mateo, Y., Gelman, D. M., Noain, D., Shin, J. H., Low, M. J., Alvarez, V. A., Lovinger, D. M. and Rubinstein, M. (2011) Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nat. Neurosci. 14, 1033-1038.
  3. Bhargava, H. N. (1980) Cyclo (leucylglycine) inhibits the development of morphine induced analgesic tolerance and dopamine receptor supersensitivity in rats. Life Sci. 27, 117-123.
  4. Blander, A., Hunt, T., Blair, R. and Amit, Z. (1984) Conditioned place preference: an evaluation of morphine's positive reinforcing properties. Psychopharmacology 84, 124-127.
  5. Bozarth, M. A. and Wise, R. A. (1981) Heroin reward is dependent on a dopaminergic substrate. Life Sci. 29, 1881-1886.
  6. de Almeida, A. A., Costa, J. P., de Carvalho, R. B., de Sousa, D. P. and de Freitas, R. M. (2012) Evaluation of acute toxicity of a natural compound (+)-limonene epoxide and its anxiolytic-like action. Brain Res. 1448, 56-62.
  7. do Amaral, J. F., Silva, M. I., Neto, M. R., Neto, P. F., Moura, B. A., de Melo, C. T., de Araujo, F. L., de Sousa, D. P., de Vasconcelos, P. F., de Vasconcelos, S. M. and de Sousa, F. C. (2007) Antinociceptive effect of the monoterpene R-(+)-limonene in mice. Biol. Pharm. Bull. 30, 1217-1220.
  8. Filip, M., Frankowska, M., Golda, A., Zaniewska, M., Vetulani, J. and Przegalinski, E. (2006) Various GABA-mimetic drugs differently affect cocaine-evoked hyperlocomotion and sensitization. Eur. J. Pharmacol. 541, 163-170.
  9. Flamm, W. G. and Lehman-McKeeman, L. D. (1991) The human relevance of the renal tumor-inducing potential of d-limonene in male rats: implications for risk assessment. Regul. Toxicol. Pharmacol. 13, 70-86.
  10. Fukushima, S., Shen, H., Hata, H., Ohara, A., Ohmi, K., Ikeda, K., Numachi, Y., Kobayashi, H., Hall, F. S., Uhl, G. R. and Sora, I. (2007) Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice. Psychopharmacology 193, 55-62.
  11. Gilbert, D. and Cooper, S. J. (1983) ${\beta}$-phenylethylamine-, d-amphetamine-and l-amphetamine-induced place preference conditioning in rats. Eur. J. Pharmacol. 95, 311-314.
  12. Henry, D. J., Hu, X. T. and White, F. J. (1998) Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitization. Psychopharmacology 140, 233-242.
  13. Hooks, M. S., Jones, G. H., Hemby, S. E. and Justice, J. B., Jr. (1993) Environmental and pharmacological sensitization: effects of repeated administration of systemic or intra-nucleus accumbens cocaine. Psychopharmacology 111, 109-116.
  14. Kim, H. S. and Jang, C. G. (1997) MK-801 inhibits methamphetamineinduced conditioned place preference and behavioral sensitization to apomorphine in mice. Brain Res. Bull. 44, 221-227.
  15. Kim, H. S., Jang, C. G., Oh, K. W., Oh, S., Rheu, H. M., Rhee, G. S., Seong, Y. H. and Park, W. K. (1998) Effects of ginseng total saponin on morphine-induced hyperactivity and conditioned place preference in mice. J. Ethnopharmacol. 60, 33-42.
  16. Kim, H. S., Jang, C. G. and Park, W. K. (1996a) Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice. Pharmacol. Biochem. Behav. 55, 11-17.
  17. Kim, H. S., Kang, J. G., Seong, Y. H., Nam, K. Y. and Oh, K. W. (1995) Blockade by ginseng total saponin of the development of cocaine induced reverse tolerance and dopamine receptor supersensitivity in mice. Pharmacol. Biochem. Behav. 50, 23-27.
  18. Kim, H. S., Lim, H. K. and Park, W. K. (1999) Antinarcotic effects of the velvet antler water extract on morphine in mice. J. Ethnopharmacol. 66, 41-49.
  19. Kim, H. S., Park, W. K., Jang, C. G. and Oh, S. (1996b) Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice. Brain Res. Bull. 40, 201-207.
  20. Klitenick, M. A., DeWitte, P. and Kalivas, P. W. (1992) Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J. Neurosci. 12, 2623-2632.
  21. Lima, N. G., De Sousa, D. P., Pimenta, F. C., Alves, M. F., De Souza, F. S., Macedo, R. O., Cardoso, R. B., de Morais, L. C., Melo Diniz Mde, F. and de Almeida, R. N. (2013) Anxiolytic-like activity and GC-MS analysis of (R)-(+)-limonene fragrance, a natural compound found in foods and plants. Pharmacol. Biochem. Behav. 103, 450-454.
  22. Martin, J. R. and Takemori, A. E. (1986) Chronically administered morphine increases dopamine receptor sensitivity in mice. Eur. J. Pharmacol. 121, 221-229.
  23. Mattingly, B. A., Rice, L. L., Langfels, M. and Fields, S. E. (2000) Repeated treatments with 7-OH-DPAT: context-independent behavioral sensitization and conditioned hyperactivity. Pharmacol. Biochem. Behav. 65, 241-246.
  24. Morency, M. A., Stewart, R. J. and Beninger, R. J. (1987) Circling behavior following unilateral microinjections of cocaine into the medial prefrontal cortex: dopaminergic or local anesthetic effect? J. Neurosci. 7, 812-818.
  25. Morgan, A. E. and Dewey, S. L. (1998) Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine. Synapse 28, 60-65.<60::AID-SYN7>3.0.CO;2-A
  26. Nonaka, R. and Moroji, T. (1990) Effects of chronic methamphetamine treatment on the binding parameters of [3H]SCH 23390, a selective D1-dopamine receptor ligand, in the rat brain. Neurosci. Lett. 120, 109-112.
  27. Ohmori, T., Abekawa, T., Muraki, A. and Koyama, T. (1994) Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine. Pharmacol. Biochem. Behav. 48, 587-591.
  28. Pak, A. C., Ashby, C. R., Jr., Heidbreder, C. A., Pilla, M., Gilbert, J., Xi, Z. X. and Gardner, E. L. (2006) The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Int. J. Neuropsychopharmacol. 9, 585-602.
  29. Reed, E., Hardy, M., Brensilver, J., Lattes, C., McCabe, R., D'Gati, V., Reemtsma, K. and Suciu-Foca, N. (1987) Anti-idiotypic antibodies to HLA and their influence on patient sensitization. Transplant. Proc. 19, 762-763.
  30. Reid, L. D., Marglin, S. H., Mattie, M. E. and Hubbell, C. L. (1989) Measuring morphine's capacity to establish a place preference. Pharmacol. Biochem. Behav. 33, 765-775.
  31. Ritzmann, R. F., Walter, R., Bhargava, H. N., Flexner, L. B. (1979) Blockage of narcotic-induced dopamine receptor supersensitivity by cyclo(Leu-Gly). Proc. Natl. Acad. Sci. U.S.A. 76, 5997-5998.
  32. Robinson, T. E. and Becker, J. B. (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396, 157-198.
  33. Shen, F., Meredith, G. E. and Napier, T. C. (2006) Amphetamine-induced place preference and conditioned motor sensitization requires activation of tyrosine kinase receptors in the hippocampus. J. Neurosci. 26, 11041-11051.
  34. Shimosato, K. and Ohkuma, S. (2000) Simultaneous monitoring of conditioned place preference and locomotor sensitization following repeated administration of cocaine and methamphetamine. Pharmacol. Biochem. Behav. 66, 285-292.
  35. Sun, J. (2007) D-Limonene: safety and clinical applications. Altern. Med. Rev. 12, 259-264.
  36. Ujike, H., Akiyama, K. and Otsuki, S. (1990) D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Psychopharmacology 102, 459-464.
  37. Ujike, H., Onoue, T., Akiyama, K., Hamamura, T. and Otsuki, S. (1989) Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology 98, 89-92.
  38. Wolf, M. E., White, F. J. and Hu, X. T. (1994) MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J. Neurosci. 14, 1735-1745.
  39. Woo, S. H., Kim, H. S., Yun, J. S., Lee, M. K., Oh, K. W., Seong, Y. H., Oh, S. K. and Jang, C. G. (2001) Inhibition of baclofen on morphine-induced hyperactivity, reverse tolerance and postsynaptic dopamine receptor supersensitivity. Pharmacol. Res. 43, 335-340.
  40. Yoo, J. H., Lee, H. K., Kim, H. C., Lee, S. Y. and Jang, C. G. (2010) GABA(A) receptors mediate the attenuating effects of a 5-HT(3) receptor antagonist on methamphetamine-induced behavioral sensitization in mice. Synapse 64, 274-279.
  41. Yun, J. (2014) Limonene inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal function and dopamine release. Phytomedicine 21, 883-887.
  42. Zhang, X., Lee, T. H., Xiong, X., Chen, Q., Davidson, C., Wetsel, W. C. and Ellinwood, E. H. (2006) Methamphetamine induces long-term changes in GABAA receptor alpha2 subunit and GAD67 expression. Biochem. Biophys. Res. Commun. 351, 300-305.
  43. Zhou, W., Yoshioka, M. and Yokogoshi, H. (2009) Sub-chronic effects of s-limonene on brain neurotransmitter levels and behavior of rats. J. Nutr. Sci. Vitaminol. (Tokyo) 55, 367-373.